HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jecko Thachil Selected Research

Thrombin

1/2022Nonovert disseminated intravascular coagulation (DIC) in pregnancy: a new scoring system for the identification of patients at risk for obstetrical hemorrhage requiring blood product transfusion.
8/2020Rivaroxaban compared to no treatment in ER-negative stage I-III early breast cancer patients (the TIP Trial): study protocol for a phase II preoperative window-of-opportunity study design randomised controlled trial.
1/2017How do we approach thrombocytopenia in critically ill patients?
1/2010Appropriate use of D-dimer in hospital patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jecko Thachil Research Topics

Disease

40Thrombosis (Thrombus)
01/2024 - 06/2008
36Disseminated Intravascular Coagulation
01/2023 - 07/2009
30Hemorrhage
01/2024 - 09/2013
29Sepsis (Septicemia)
04/2024 - 08/2011
25Thrombocytopenia (Thrombopenia)
03/2024 - 10/2006
23COVID-19
03/2024 - 01/2020
14Venous Thromboembolism
12/2023 - 01/2010
12Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
03/2024 - 02/2009
9Neoplasms (Cancer)
03/2024 - 08/2011
7Atrial Fibrillation
12/2023 - 04/2014
7Wounds and Injuries (Trauma)
11/2022 - 06/2013
6Hemophilia A (Haemophilia)
08/2023 - 01/2015
6Infections
01/2023 - 04/2014
5Critical Illness (Critically Ill)
10/2022 - 09/2013
5Hemolysis
09/2022 - 05/2013
4Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
07/2023 - 01/2013
4Stroke (Strokes)
01/2023 - 10/2016
4Confusion (Bewilderment)
11/2022 - 08/2016
4Abruptio Placentae (Placental Abruption)
09/2022 - 07/2009
4Venous Thrombosis (Deep-Vein Thrombosis)
07/2022 - 11/2012
4Pre-Eclampsia (Preeclampsia)
08/2019 - 07/2009
3Chronic Renal Insufficiency
12/2023 - 10/2018
3Fibrosis (Cirrhosis)
11/2023 - 01/2022
3Virus Diseases (Viral Diseases)
08/2023 - 10/2021
3Thrombophilia
08/2023 - 10/2016
3Thromboembolism
08/2023 - 01/2020
3HELLP Syndrome
09/2022 - 08/2019
3Stillbirth
09/2022 - 10/2015
2Nephrotic Syndrome (Syndrome, Nephrotic)
12/2023 - 02/2007
2Liver Diseases (Liver Disease)
11/2023 - 01/2021
2Disease Progression
01/2023 - 11/2022
2Communicable Diseases (Infectious Diseases)
01/2023 - 01/2021
2Inflammation (Inflammations)
09/2022 - 01/2019
2Eclampsia
09/2022 - 10/2015
2Acute fatty liver of pregnancy
01/2022 - 10/2015
2Amniotic Fluid Embolism
01/2022 - 07/2009
2Cardiovascular Diseases (Cardiovascular Disease)
01/2019 - 11/2015
2Thrombotic Thrombocytopenic Purpura
12/2009 - 08/2008
2Sarcoidosis (Schaumann Disease)
07/2009 - 08/2007
1Hyperglycemia
04/2024
1Fatty Liver
11/2023
1Alcoholic Liver Diseases (Alcoholic Liver Disease)
11/2023
1Disease Susceptibility (Diathesis)
08/2023
1Snake Bites (Snake Bite)
07/2023

Drug/Important Bio-Agent (IBA)

35AnticoagulantsIBA
04/2024 - 02/2007
34Dacarbazine (DIC)FDA LinkGeneric
01/2023 - 07/2009
14Inosine Triphosphate (ITP)IBA
03/2024 - 02/2009
11Heparin (Liquaemin)FDA LinkGeneric
03/2024 - 06/2008
10fibrin fragment D (D-dimer)IBA
09/2022 - 01/2010
10Fibrinogen (Factor I)FDA Link
01/2022 - 09/2017
9AntithrombinsIBA
01/2022 - 05/2015
7Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
03/2024 - 01/2013
7Hemostatics (Antihemorrhagics)IBA
08/2023 - 07/2019
6EnzymesIBA
03/2024 - 12/2009
5Protein CIBA
01/2022 - 08/2011
5ThrombomodulinIBA
01/2019 - 03/2016
4FibrinIBA
08/2023 - 01/2010
4Warfarin (Coumadin)FDA LinkGeneric
11/2022 - 03/2014
4ThrombinFDA Link
01/2022 - 01/2010
3VaccinesIBA
03/2024 - 09/2022
3Thrombopoietin ReceptorsIBA
03/2024 - 01/2018
3AntibodiesIBA
07/2023 - 04/2010
3Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2023 - 01/2020
3Blood Coagulation Factors (Coagulation Factor)IBA
01/2023 - 08/2020
3SteroidsIBA
01/2019 - 06/2013
3Rituximab (Mabthera)FDA Link
05/2011 - 10/2006
2Adrenal Cortex Hormones (Corticosteroids)IBA
04/2024 - 04/2014
2romiplostimFDA Link
03/2024 - 10/2013
2Fibrinolytic Agents (Antithrombotic Agents)IBA
11/2023 - 10/2022
2Factor XI (Plasma Thromboplastin Antecedent)IBA
08/2023 - 08/2017
2Biomarkers (Surrogate Marker)IBA
01/2023 - 01/2021
2RivaroxabanIBA
10/2022 - 08/2020
2Antithrombin IIIIBA
01/2022 - 07/2016
2Factor VIII (Coagulation Factor VIII)IBA
01/2021 - 01/2015
2Fibrin Fibrinogen Degradation ProductsIBA
12/2020 - 09/2017
2Acute-Phase Proteins (Acute-Phase Protein)IBA
08/2020 - 09/2013
2Histones (Histone)IBA
01/2017 - 09/2013
2Indicators and Reagents (Reagents)IBA
01/2017 - 05/2011
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2017 - 06/2008
2Dalteparin (Dalteparin Sodium)FDA Link
10/2016 - 03/2014
2Immunoglobulin G (IgG)IBA
01/2015 - 06/2008
2AutoantibodiesIBA
01/2015 - 04/2014
2Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2013 - 02/2009
2Alemtuzumab (Campath)FDA Link
08/2007 - 07/2007
1CatecholaminesIBA
04/2024
1Phenobarbital (Luminal)FDA Link
04/2024
1eltrombopagFDA Link
03/2024
1fostamatinibIBA
01/2024
1Factor Xa InhibitorsIBA
12/2023
1AS 8IBA
08/2023
1Factor XII (Hageman Factor)IBA
08/2023
1Viper Venoms (Viper Venom)IBA
07/2023

Therapy/Procedure

23Therapeutics
01/2024 - 04/2012
5Critical Care (Surgical Intensive Care)
01/2017 - 01/2009
4Platelet Transfusion (Blood Platelet Transfusions)
01/2017 - 08/2010
2Resuscitation
04/2024 - 03/2020
2Contraindications
10/2022 - 07/2021
2Splenectomy
10/2022 - 04/2014
2Catheters
07/2022 - 05/2016
1Liver Transplantation
11/2023